- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Aliquots are pre-aliquoted, commercially available drugs from the EU. Our aliquots thus contain therapeutic molecules manufactured by the original drug license holder and repackaged by Evidentic.
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
SARS-CoV-2 Spike |
Monoclonal Antibody |
Evusheld® |
100 mg/mL |
– |
4 mg |
tba |
tba |
515,00 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
10/2021 |
115,20 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
05/2018 |
115,20 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
03/2019 |
115,20 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
05/2019 |
115,20 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
03/2020 |
115,20 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Herzuma® |
21 mg/mL |
– |
2 mg |
tba |
tba |
159,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Kanjinti® |
21 mg/mL |
– |
2 mg |
tba |
tba |
159,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Ogivri® |
21 mg/mL |
– |
2 mg |
tba |
tba |
159,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Ontruzant® |
21 mg/mL |
– |
2 mg |
tba |
tba |
159,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Zercepac® |
21 mg/mL |
– |
2 mg |
tba |
tba |
159,00 € |
||
HER2 |
Antibody-drug conjugate (ADC) |
Enhertu® |
20 mg/mL |
– |
2 mg |
-80°C |
08/2026 |
482,00 € |
||
HER2 |
Antibody-drug conjugate (ADC) |
Kadcyla® |
20 mg/mL |
– |
2 mg |
-80°C |
07/2023 |
348,30 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Trazimera® |
21 mg/mL |
– |
2 mg |
-80 °C |
09/2026 |
159,00 € |
||
HER2 |
Monoclonal Antibody |
Herceptin® |
21 mg/mL |
– |
2 mg |
-80°C |
08/2020 |
147,60 € |
||
HER2 |
Monoclonal Antibody |
Herceptin® |
21 mg/mL |
– |
2 mg |
-80°C |
02/2021 |
147,60 € |
||
HER2 |
Monoclonal Antibody |
Herceptin® |
21 mg/mL |
– |
2 mg |
-80°C |
08/2021 |
147,60 € |
||
HER2 |
Monoclonal Antibody |
Herceptin® |
21 mg/mL |
– |
2 mg |
-80°C |
11/2019 |
147,60 € |
||
HER2 |
Monoclonal Antibody |
Herceptin® |
21 mg/mL |
– |
2 mg |
-80°C |
12/2020 |
147,60 € |
||
HER2 |
Monoclonal Antibody |
Herceptin® |
21 mg/mL |
– |
2 mg |
-80°C |
03/2023 |
147,60 € |
||
HER2 |
Monoclonal Antibody |
Herceptin® |
21 mg/mL |
– |
2 mg |
-80°C |
11/2024 |
164,00 € |
||
IL-12 |
Monoclonal Antibody |
Stelara® |
90 mg/mL |
– |
4 mg |
-80°C |
10/2018 |
1.005,30 € |
||
IL-12 |
Monoclonal Antibody |
Stelara® |
90 mg/mL |
– |
4 mg |
-80°C |
02/2019 |
1.005,30 € |
||
IL-12 |
Monoclonal Antibody |
Stelara® |
90 mg/mL |
– |
4 mg |
-80°C |
05/2019 |
1.005,30 € |
||
IL-12 |
Monoclonal Antibody |
Stelara® |
90 mg/mL |
– |
4 mg |
-80°C |
08/2019 |
1.005,30 € |
||
IL-12 |
Monoclonal Antibody |
Stelara® |
90 mg/mL |
– |
4 mg |
-80°C |
12/2019 |
1.005,30 € |
||
IL-12 |
Monoclonal Antibody |
Stelara® |
90 mg/mL |
– |
4 mg |
-80°C |
04/2021 |
1.005,30 € |
||
IL-12 |
Monoclonal Antibody |
Stelara® |
90 mg/mL |
– |
4 mg |
-80°C |
10/2025 |
1.117,00 € |
||
alpha 4 beta 7 integrin |
Monoclonal Antibody |
Entyvio® |
158,8 mg/mL |
– |
4 mg |
-80°C |
06/2024 |
325,00 € |
||
alpha 4 beta 7 integrin |
Monoclonal Antibody |
Entyvio® |
158,8 mg/mL |
– |
4 mg |
-80°C |
12/2021 |
292,50 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin